KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Common Equity (2016 - 2026)

Eli Lilly filings provide 18 years of Common Equity readings, the most recent being $31.2 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 106.61% to $31.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $31.2 billion, a 106.61% increase, with the full-year FY2025 number at $26.5 billion, up 1210.25% from a year prior.
  • Common Equity hit $31.2 billion in Q1 2026 for Eli Lilly, up from $26.5 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $31.2 billion in Q1 2026 to a low of -$3.8 billion in Q4 2022.
  • Median Common Equity over the past 5 years was -$2.2 billion (2025), compared with a mean of $4.6 billion.
  • The widest YoY moves for Common Equity: up 46277.37% in 2025, down 6607.65% in 2025.
  • Eli Lilly's Common Equity stood at -$3.8 billion in 2022, then increased by 29.86% to -$2.7 billion in 2023, then rose by 11.38% to -$2.4 billion in 2024, then soared by 1210.25% to $26.5 billion in 2025, then rose by 17.57% to $31.2 billion in 2026.
  • The last three reported values for Common Equity were $31.2 billion (Q1 2026), $26.5 billion (Q4 2025), and $23.8 billion (Q3 2025) per Business Quant data.